Align Technology (ALGN)
Market Price (9/16/2025): $131.0 | Market Cap: $9.5 BilSector: Health Care | Industry: Health Care Supplies
Align Technology (ALGN)
Market Price (9/16/2025): $131.0Market Cap: $9.5 BilSector: Health CareIndustry: Health Care Supplies
Investment Highlights
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 16% | Weak multi-year price returns2Y Excs Rtn is -108%, 3Y Excs Rtn is -114% | Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.1%, Rev Chg QQuarterly Revenue Change % is -1.6% |
Attractive yieldFCF Yield is 6.6% |
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 16% |
Attractive yieldFCF Yield is 6.6% |
Weak multi-year price returns2Y Excs Rtn is -108%, 3Y Excs Rtn is -114% |
Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.1%, Rev Chg QQuarterly Revenue Change % is -1.6% |
Market Valuation
9/16/25 | 2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|---|
Share Price CYE | $131.00 | $208.51 | $274.00 | $210.90 | $657.18 |
Market Cap CYE ($ Bil) | 9.5 | 15.5 | 20.7 | 16.4 | 51.8 |
Total Debt ($ Bil) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Total Cash ($ Bil) | 0.9 | 1.0 | 1.0 | 1.0 | 1.2 |
Enterprise Value ($ Bil) | 8.7 | 15.6 | 20.8 | 16.5 | 51.9 |
Valuation Ratios | |||||
P/S TTM | 2.4 | 3.9 | 5.4 | 4.4 | 13.1 |
P/EBIT TTM | 14.9 | 23.2 | 31.9 | 25.2 | 53.1 |
P/E TTM | 21.7 | 37.0 | 47.0 | 45.6 | 67.2 |
Sector Ratios | |||||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 | 4.5 | 7.3 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 | -1.3 | -2.9 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 | -1.4 | -2.9 |
9/16/25 | 2024 | 2023 | |
---|---|---|---|
Share Price CYE | $131.00 | $208.51 | $274.00 |
Market Cap CYE ($ Bil) | 9.5 | 15.5 | 20.7 |
Total Debt ($ Bil) | 0.1 | 0.1 | 0.1 |
Total Cash ($ Bil) | 0.9 | 1.0 | 1.0 |
Enterprise Value ($ Bil) | 8.7 | 15.6 | 20.8 |
Valuation Ratios | |||
P/S TTM | 2.4 | 3.9 | 5.4 |
P/EBIT TTM | 14.9 | 23.2 | 31.9 |
P/E TTM | 21.7 | 37.0 | 47.0 |
Sector Ratios | |||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 |
Business Description
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.
Show more
Price Returns Compared
Expand for Detailed View2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
---|---|---|---|---|---|---|---|
Returns | |||||||
ALGN Return | 92% | 23% | -68% | 30% | -24% | -37% | -53% |
Peers Return | 24% | 27% | -27% | 19% | -14% | -11% | 5% |
S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 12% | 104% |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: STE, HSIC, XRAY, WST, COO. See ALGN Returns vs. Peers.
[3] 2025 data is for the year up to 9/15/2025 (YTD)
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Align Technology
Financials
Median | |
---|---|
Name | |
Mkt Price | 99.94 |
Mkt Cap | 11.3 |
Rev LTM | 4,005 |
Op Inc LTM | 689 |
FCF LTM | 378 |
FCF 3Y Avg | 401 |
CFO LTM | 704 |
CFO 3Y Avg | 685 |
Growth & Margins
Median | |
---|---|
Name | |
Rev Chg LTM | 2.6% |
Rev Chg 3Y Avg | 0.3% |
Rev Chg Q | 4.5% |
QoQ Delta Rev Chg LTM | 1.1% |
Op Mgn LTM | 17.0% |
Op Mgn 3Y Avg | 16.4% |
QoQ Delta Op Mgn LTM | 0.1% |
CFO/Rev LTM | 19.3% |
CFO/Rev 3Y Avg | 17.9% |
FCF/Rev LTM | 10.9% |
FCF/Rev 3Y Avg | 9.9% |
Valuation
Median | |
---|---|
Name | |
Mkt Cap | 11.3 |
P/S | 2.8 |
P/EBIT | 16.5 |
P/E | 26.9 |
P/CFO | 16.2 |
Total Yield | 3.3% |
Dividend Yield | 0.1% |
FCF Yield 3Y Avg | 3.0% |
D/E | 0.1 |
Net D/E | 0.1 |
Returns
Median | |
---|---|
Name | |
1M Rtn | -0.5% |
3M Rtn | -4.4% |
6M Rtn | -7.8% |
12M Rtn | -27.4% |
3Y Rtn | -7.1% |
1M Excs Rtn | -3.0% |
3M Excs Rtn | -14.7% |
6M Excs Rtn | -24.2% |
12M Excs Rtn | -46.2% |
3Y Excs Rtn | -80.5% |
Comparison Analyses
Segment Financials
Revenue by Segment
$ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Clear Aligner | 3,199 | 3,073 | 3,247 | 2,101 | 2,026 |
Systems and Services | 663 | 662 | 706 | 370 | 381 |
Total | 3,862 | 3,735 | 3,953 | 2,472 | 2,407 |
$ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Clear Aligner | 1,182 | 1,134 | 1,326 | 768 | 836 |
Systems and Services | 191 | 180 | 259 | 96 | 138 |
Unallocated corporate expenses | -730 | -672 | -609 | -477 | -431 |
Total | 643 | 643 | 976 | 387 | 542 |
Returns Analyses
Earnings Returns History
Expand for MoreForward Returns | |||
---|---|---|---|
Earnings Date | 1D Returns | 5D Returns | 21D Returns |
7/30/2025 | -36.6% | -32.8% | -30.7% |
4/30/2025 | 2.0% | -0.6% | 4.4% |
2/5/2025 | 0.9% | -5.1% | -19.7% |
10/23/2024 | 4.2% | 1.5% | 9.9% |
7/24/2024 | -7.7% | -5.3% | -6.6% |
4/24/2024 | -1.0% | -9.3% | -19.6% |
1/31/2024 | 2.3% | 6.5% | 12.2% |
10/25/2023 | -24.9% | -27.8% | -13.5% |
... | |||
SUMMARY STATS | |||
# Positive | 13 | 12 | 11 |
# Negative | 11 | 12 | 13 |
Median Positive | 7.5% | 9.9% | 11.4% |
Median Negative | -7.7% | -8.3% | -13.5% |
Max Positive | 35.0% | 30.9% | 31.4% |
Max Negative | -36.6% | -32.8% | -30.7% |
SEC Filings
Expand for MoreReport Date | Filing Date | Filing |
---|---|---|
6302025 | 8062025 | 10-Q 6/30/2025 |
3312025 | 5082025 | 10-Q 3/31/2025 |
12312024 | 2282025 | 10-K 12/31/2024 |
9302024 | 11052024 | 10-Q 9/30/2024 |
6302024 | 8022024 | 10-Q 6/30/2024 |
3312024 | 5032024 | 10-Q 3/31/2024 |
12312023 | 2282024 | 10-K 12/31/2023 |
9302023 | 11032023 | 10-Q 9/30/2023 |
6302023 | 8042023 | 10-Q 6/30/2023 |
3312023 | 5052023 | 10-Q 3/31/2023 |
12312022 | 2272023 | 10-K 12/31/2022 |
9302022 | 11042022 | 10-Q 9/30/2022 |
6302022 | 8042022 | 10-Q 6/30/2022 |
3312022 | 5052022 | 10-Q 3/31/2022 |
12312021 | 2252022 | 10-K 12/31/2021 |
9302021 | 11022021 | 10-Q 9/30/2021 |
External Quote Links
Y Finance | Barrons |
TradingView | Morningstar |
SeekingAlpha | ValueLine |
Motley Fool | Robinhood |
CNBC | Etrade |
MarketWatch | Unusual Whales |
YCharts | Perplexity Finance |
FinViz |